vs

Side-by-side financial comparison of Franklin Resources (BEN) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

Franklin Resources is the larger business by last-quarter revenue ($2.3B vs $1.5B, roughly 1.6× BeOne Medicines Ltd.). Franklin Resources runs the higher net margin — 11.0% vs 4.4%, a 6.5% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 3.4%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 4.0%).

Franklin Resources, Inc. is an American multinational investment management holding company that, together with its subsidiaries, is referred to as Franklin Templeton; it is a global investment firm founded in New York City in 1947 as Franklin Distributors, Inc. It is listed on the New York Stock Exchange under the ticker symbol BEN, in honor of Benjamin Franklin, for whom the company is named, and who was admired by founder Rupert Johnson Sr. In 1973, the company's headquarters moved from Ne...

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

BEN vs ONC — Head-to-Head

Bigger by revenue
BEN
BEN
1.6× larger
BEN
$2.3B
$1.5B
ONC
Growing faster (revenue YoY)
ONC
ONC
+29.5% gap
ONC
32.8%
3.4%
BEN
Higher net margin
BEN
BEN
6.5% more per $
BEN
11.0%
4.4%
ONC
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
4.0%
BEN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BEN
BEN
ONC
ONC
Revenue
$2.3B
$1.5B
Net Profit
$255.5M
$66.5M
Gross Margin
90.5%
Operating Margin
12.1%
12.4%
Net Margin
11.0%
4.4%
Revenue YoY
3.4%
32.8%
Net Profit YoY
56.2%
143.8%
EPS (diluted)
$0.46
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BEN
BEN
ONC
ONC
Q4 25
$2.3B
$1.5B
Q3 25
$2.3B
$1.4B
Q2 25
$2.1B
$1.3B
Q1 25
$2.1B
$1.1B
Q4 24
$2.3B
$1.1B
Q3 24
$2.2B
$1.0B
Q2 24
$2.1B
$929.2M
Q1 24
$2.2B
$751.7M
Net Profit
BEN
BEN
ONC
ONC
Q4 25
$255.5M
$66.5M
Q3 25
$117.6M
$124.8M
Q2 25
$92.3M
$94.3M
Q1 25
$151.4M
$1.3M
Q4 24
$163.6M
$-151.9M
Q3 24
$-84.7M
$-121.3M
Q2 24
$174.0M
$-120.4M
Q1 24
$124.2M
$-251.2M
Gross Margin
BEN
BEN
ONC
ONC
Q4 25
90.5%
Q3 25
86.1%
Q2 25
87.5%
Q1 25
85.2%
Q4 24
85.8%
Q3 24
83.0%
Q2 24
85.1%
Q1 24
83.4%
Operating Margin
BEN
BEN
ONC
ONC
Q4 25
12.1%
12.4%
Q3 25
3.6%
11.5%
Q2 25
7.5%
6.7%
Q1 25
6.9%
1.0%
Q4 24
9.7%
-7.0%
Q3 24
-6.8%
-12.0%
Q2 24
10.5%
-11.5%
Q1 24
6.0%
-34.8%
Net Margin
BEN
BEN
ONC
ONC
Q4 25
11.0%
4.4%
Q3 25
5.0%
8.8%
Q2 25
4.5%
7.2%
Q1 25
7.2%
0.1%
Q4 24
7.3%
-13.5%
Q3 24
-3.8%
-12.1%
Q2 24
8.2%
-13.0%
Q1 24
5.8%
-33.4%
EPS (diluted)
BEN
BEN
ONC
ONC
Q4 25
$0.46
$0.05
Q3 25
$0.21
$0.08
Q2 25
$0.15
$0.06
Q1 25
$0.26
$0.00
Q4 24
$0.29
$-0.10
Q3 24
$-0.20
$-0.09
Q2 24
$0.32
$-0.09
Q1 24
$0.23
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BEN
BEN
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$4.5B
Total DebtLower is stronger
$2.4B
$836.4M
Stockholders' EquityBook value
$12.1B
$4.4B
Total Assets
$32.5B
$8.2B
Debt / EquityLower = less leverage
0.19×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BEN
BEN
ONC
ONC
Q4 25
$4.5B
Q3 25
$4.0B
Q2 25
$2.8B
Q1 25
$2.5B
Q4 24
$2.6B
Q3 24
$2.7B
Q2 24
$2.6B
Q1 24
$2.8B
Total Debt
BEN
BEN
ONC
ONC
Q4 25
$2.4B
$836.4M
Q3 25
$2.4B
Q2 25
$2.7B
Q1 25
$2.7B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$3.0B
Q1 24
$3.0B
Stockholders' Equity
BEN
BEN
ONC
ONC
Q4 25
$12.1B
$4.4B
Q3 25
$12.1B
$4.1B
Q2 25
$12.2B
$3.8B
Q1 25
$12.3B
$3.5B
Q4 24
$12.5B
$3.3B
Q3 24
$12.5B
$3.4B
Q2 24
$12.9B
$3.4B
Q1 24
$12.9B
$3.4B
Total Assets
BEN
BEN
ONC
ONC
Q4 25
$32.5B
$8.2B
Q3 25
$32.4B
$7.6B
Q2 25
$32.6B
$6.3B
Q1 25
$32.0B
$5.8B
Q4 24
$32.4B
$5.9B
Q3 24
$32.5B
$5.8B
Q2 24
$33.3B
$5.7B
Q1 24
$32.9B
$5.7B
Debt / Equity
BEN
BEN
ONC
ONC
Q4 25
0.19×
0.19×
Q3 25
0.20×
Q2 25
0.22×
Q1 25
0.22×
Q4 24
0.22×
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BEN
BEN
ONC
ONC
Operating Cash FlowLast quarter
$-255.1M
$417.3M
Free Cash FlowOCF − Capex
$379.8M
FCF MarginFCF / Revenue
25.4%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
-1.00×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BEN
BEN
ONC
ONC
Q4 25
$-255.1M
$417.3M
Q3 25
$-20.7M
$402.6M
Q2 25
$1.3B
$263.6M
Q1 25
$-50.1M
$44.1M
Q4 24
$-145.2M
$75.2M
Q3 24
$558.2M
$188.4M
Q2 24
$528.4M
$-95.6M
Q1 24
$136.6M
$-308.6M
Free Cash Flow
BEN
BEN
ONC
ONC
Q4 25
$379.8M
Q3 25
$-51.9M
$354.5M
Q2 25
$1.3B
$219.8M
Q1 25
$-87.6M
$-12.3M
Q4 24
$-217.0M
$-17.3M
Q3 24
$488.4M
$54.7M
Q2 24
$482.3M
$-205.5M
Q1 24
$94.9M
$-465.1M
FCF Margin
BEN
BEN
ONC
ONC
Q4 25
25.4%
Q3 25
-2.2%
25.1%
Q2 25
61.4%
16.7%
Q1 25
-4.1%
-1.1%
Q4 24
-9.6%
-1.5%
Q3 24
22.1%
5.5%
Q2 24
22.7%
-22.1%
Q1 24
4.4%
-61.9%
Capex Intensity
BEN
BEN
ONC
ONC
Q4 25
2.5%
Q3 25
1.3%
3.4%
Q2 25
0.7%
3.3%
Q1 25
1.8%
5.0%
Q4 24
3.2%
8.2%
Q3 24
3.2%
13.3%
Q2 24
2.2%
11.8%
Q1 24
1.9%
20.8%
Cash Conversion
BEN
BEN
ONC
ONC
Q4 25
-1.00×
6.28×
Q3 25
-0.18×
3.22×
Q2 25
13.89×
2.79×
Q1 25
-0.33×
34.71×
Q4 24
-0.89×
Q3 24
Q2 24
3.04×
Q1 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BEN
BEN

Investment Advisory Management And Administrative Service$1.8B79%
Sales And Distribution Fees$388.7M17%
Shareholder Service$70.9M3%
Service Other$19.6M1%

ONC
ONC

Segment breakdown not available.

Related Comparisons